Skip to main content
SpringerLink
Log in

Management of direct oral anticoagulant drug interactions in hospitalized patients

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Moderate-strong CYP3A4 or Pgp inhibitors and inducers alter direct oral anticoagulant (DOAC) pharmacokinetics. Whether the presence of a DOAC drug-drug interaction (DDI) prompts in- hospital changes in management remains unknown. We identified all hospitalized patients at our institution who were admitted with a clinically relevant DOAC DDI from 01/2021 to 06/2021. Clinically relevant DOAC DDIs were defined as those listed in the prescribing information or FDA CYP3A4/Pgp inhibitors clinical indexes. We assessed the prevalence of DOAC DDIs and categorized their management as: drug stopped, drug held, or drug continued. For drugs that were continued we assessed whether the dose of the DOAC or interacting drug was increased, decreased or unchanged during the admission. We ascertained the number of DOAC DDIs that prompted an automated prescribing alert in our electronic health record (EHR). Finally, we conducted a logistic regression model to compare users of DOACs with DDI who had their regimen adjusted versus those without adjustments, focusing on outcomes of rehospitalization and death, adjusting for age and gender. Among 3,725 hospitalizations with a DOAC admission order, 197 (5%) had a clinically relevant DOAC DDI. The DOAC and the interacting drug were continued at discharge for 124 (63%) hospitalizations. The most frequent adjustments were stopping the interacting drug (73%) and stopping the DOAC (15%). Only 7 (4%) of DOAC DDIs prompted an EHR alert. The adjusted odds ratios for rehospitalizations and death, respectively, among patients whose regimens were adjusted compared to those whose were not, were 1.29 (95% CI, 0.67 to 2.48; P = 0.44) and 1.88 (95% CI, 0.91 to 3.89; P = 0.09). Clinically relevant DDIs with DOACs occur infrequently among hospitalized patients and usually are managed without stopping the DOAC. The clinical impact of such DDIs and subsequent adjustments on thrombotic and hemorrhagic outcomes requires further investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Forbes HL, Polasek TM (2017) Potential drug-drug interactions with direct oral anticoagulants in elderly hospitalized patients. Ther Adv Drug Safe 8(10):319–328. https://doi.org/10.1177/2042098617719815

    Article  CAS  Google Scholar 

  2. Kaaber AB, Jans Ø, Dziegiel MH, Stensballe J, Johansson PI (2021) Managing patients on direct factor Xa inhibitors with rapid thrombelastography. Scand J Clin Lab Invest 81(8):661–669. https://doi.org/10.1080/00365513.2021.2003855

    Article  CAS  PubMed  Google Scholar 

  3. Information P (2015) ELIQUIS(R) oral tablets, apixaban oral tablets. Bristol-Myers Squibb Company and Pfizer Inc (per FDA), Princeton, NJ

    Google Scholar 

  4. ‘Product Information: PRADAXA(R) oral capsules, dabigatran etexilate oral capsules. Boehringer Ingelheim Pharmaceuticals Inc (per FDA), Ridgefield, CT, 2021

  5. Product Information: SAVAYSA(TM) oral tablets, edoxaban oral tablets. Daiichi Sankyo, Inc. (per FDA), Parsippany, NJ, 2015.

  6. Information P (2019) XARELTO(R) oral tablets, rivaroxaban oral tablets. NJ, Janssen Pharmaceuticals Inc (per FDA), Titusville

    Google Scholar 

  7. Drug database: Medication decision support. FDB (First Databank). (n.d.). https://www.fdbhealth.com. Accessed 15 Oct 2023

  8. Hill K, Sucha E, Rhodes E, Carrier M, Garg AX, Harel Z, Hundemer GL, Clark EG, Knoll G, McArthur E, Sood MM (2020) Risk of Hospitalization With Hemorrhage Among Older Adults Taking Clarithromycin vs Azithromycin and Direct Oral Anticoagulants. JAMA Intern Med 180(8):1052–1060. https://doi.org/10.1001/jamainternmed.2020.1835

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy Services, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA, 02115, USA

    Mohsen H. Al Zaria, Leo F. Buckley, Heather Dell’orfano, Peter Manzo & John Fanikos

Authors
  1. Mohsen H. Al Zaria
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leo F. Buckley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Heather Dell’orfano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter Manzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. John Fanikos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohsen H. Al Zaria.

Ethics declarations

Disclosures

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Al Zaria, M.H., Buckley, L.F., Dell’orfano, H. et al. Management of direct oral anticoagulant drug interactions in hospitalized patients. J Thromb Thrombolysis 57, 598–602 (2024). https://doi.org/10.1007/s11239-024-02967-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-024-02967-2

Keywords

Search

Navigation